Oncopharmpod
Monthly Immunotherapy Expanded Approvals Update
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:14:57
- More information
Informações:
Synopsis
Another month, another 2 expanded FDA-approvals: nivolumab/ipilimumab for malignant pleural mesothelioma and pembrolizumab for relapsed/refractory classical Hodgkin's lymphoma.
